Susquehanna Fundamental Investments’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-17,271
Closed -$224K 808
2025
Q1
$224K Buy
+17,271
New +$229K ﹤0.01% 987
2023
Q2
Sell
-39,472
Closed -$387K 710
2023
Q1
$387K Sell
39,472
-105,511
-73% -$1.13M 0.01% 733
2022
Q4
$1.54M Buy
144,983
+35,649
+33% +$414K 0.03% 554
2022
Q3
$1.14M Buy
+109,334
New +$1.42M 0.02% 765
2022
Q1
$174K Sell
16,080
-33,490
-68% -$407K ﹤0.01% 1390
2021
Q4
$697K Hold
49,570
0.02% 795
2021
Q3
$952K Buy
+49,570
New +$658K 0.02% 887
2021
Q2
Sell
-83,183
Closed -$818K 1679
2021
Q1
$818K Buy
+83,183
New +$686K 0.01% 963
2020
Q4
Sell
-118,300
Closed -$511K 1521
2020
Q3
$511K Buy
118,300
+5,400
+5% +$38.5K 0.02% 868
2020
Q2
$1M Buy
+112,900
New +$571K 0.05% 460

Other funds holding DVAX

Susquehanna Fundamental Investments's DVAX Position: Q2 2025 in Review

Susquehanna Fundamental Investments sold out of Dynavax Technologies (DVAX) in Q2 2025, closing a stake of 17,271 shares — an estimated $224K sold.

Susquehanna Fundamental Investments first reported a position in DVAX in Q2 2020 and held it in 10 quarters. The position peaked at $1.54M in Q4 2022. 268 funds tracked by Wall St. Rank hold DVAX as of Q2 2025.

  • Susquehanna Fundamental Investments reported no remaining Dynavax Technologies position as of Q2 2025 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 17,271 Dynavax Technologies shares in Q2 2025, an estimated $224K.
  • Susquehanna Fundamental Investments first reported a position in Dynavax Technologies in Q2 2020 and held it in 10 quarters.
  • Susquehanna Fundamental Investments's Dynavax Technologies position peaked at $1.54M in Q4 2022.
  • 268 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2025, filed 14 Aug 2025.